Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Somatropin(rbe) 1.8iu(0.6mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 1.2iu(0.4mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 0.6iu(0.2mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rmc) 24iu(8mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon)+diluent+kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 12iu(4mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 2.4iu(0.8mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 3iu(1mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 5.3 milligram/1 cartridge powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 16iu(5.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rmc) 10iu(3.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rmc) 4iu(1.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 4iu(1.33mg) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin 12 mg powder for solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 18iu(6mg) powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 36iu(12mg) powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 72iu(24mg) powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 3.6iu(1.2mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 4.2iu(1.4mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 4.8iu(1.6mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 5.4iu(1.8mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(rbe) 6iu(2mg) powder and solvent for injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(epr) 3.33mg/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(epr) 6.66mg/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Somatropin(epr) 10mg/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Product containing somatotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|
Product containing somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human growth hormone recombinant |
Inferred relationship |
Some |
|